Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 205

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee

Open access
Pringsheim, Tamara, Day, Gregory S., Smith, Don B., Rae-Grant, Alex, Licking, Nicole, Armstrong, Melissa J., de Bie, Rob M.A., Roze, Emmanuel, Miyasaki, Janis M., Hauser, Robert A., Espay, Alberto J., Martello, Justin P., Gurwell, Julie A., Billinghurst, Lori, Sullivan, Kelly, Fitts, Michael S., Cothros, Nicholas, Hall, Deborah A., Rafferty, Miriam, Hagerbrant, Lynn, Hastings, Tara, O'Brien, Mary Dolan, Silsbee, Heather, Gronseth, Gary, Lang, Anthony E., on behalf of the Guideline Subcommittee of the AAN, Pringsheim, Tamara, Day, Gregory S., Smith, DonB., Rae-Grant, Alex, Licking, Nicole, Armstrong, Melissa J., de Bie, Rob M. A., Roze, Emmanuel, Miyasaki, Janis M., A.Hauser, Robert, Espay, Alberto J., Martello, Justin P., Gurwell, Julie, Billinghurst, Lori, Sullivan, Kelly, Fitts, Michael S., Cothros, Nicholas, Hall, Deborah A., Rafferty, Miriam, Hagerbrant, Lynn, Hastings, Tara, O’Brien, Mary Dolan, Silsbee, Heather, Gronseth, Gary, Lang, Anthony E. · 2021 · Neurology

Abstract

BACKGROUND AND OBJECTIVES: To review the current evidence on the options available for initiating dopaminergic treatment of motor symptoms in early-stage Parkinson disease and provide recommendations to clinicians. METHODS: A multidisciplinary panel developed practice recommendations, integrating findings from a systematic review and following an Institute of Medicine-compliant process to ensure transparency and patient engagement. Recommendations were supported by structured rationales, integrating evidence from the systematic review, related evidence, principles of care, and inferences from evidence. RESULTS: Initial treatment with levodopa provides superior motor benefit compared to treatment with dopamine agonists, whereas levodopa is more likely than dopamine agonists to cause dyskinesia. The comparison of different formulations of dopamine agonists yielded little evidence that any one formulation or method of administration is superior. Long-acting forms of levodopa and levodopa with entacapone do not appear to differ in efficacy from immediate-release levodopa for motor symptoms in early disease. There is a higher risk of impulse control disorders associated with the use of dopamine agonists than levodopa. Recommendations on initial therapy for motor symptoms are provided to assist the clinician and patient in choosing between treatment options and to guide counseling, prescribing, and monitoring of efficacy and safety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000012868

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 205

Metadata

Authors
Pringsheim, T., Day, G. S., Smith, D. B., Rae-Grant, A., Licking, N., Armstrong, M. J., de Bie, R. M. A., Roze, E., Miyasaki, J. M., Hauser, R. A., Espay, A. J., Martello, J. P., Gurwell, J. A., Billinghurst, L., Sullivan, K., Fitts, M. S., Cothros, N., Hall, D. A., Rafferty, M., Hagerbrant, L., Hastings, T., O'Brien, M. D., Silsbee, H., Gronseth, G., Lang, A. E., on behalf of the Guideline Subcommittee of the, A. A. N., Pringsheim, T., Day, G. S., Smith, D., Rae-Grant, A., Licking, N., Armstrong, M. J., de Bie, R. M. A., Roze, E., Miyasaki, J. M., A.Hauser, R., Espay, A. J., Martello, J. P., Gurwell, J., Billinghurst, L., Sullivan, K., Fitts, M. S., Cothros, N., Hall, D. A., Rafferty, M., Hagerbrant, L., Hastings, T., O’Brien, M. D., Silsbee, H., Gronseth, G., & Lang, A. E.
Venue
Neurology
Published
2021-11-16
Volume
97
Issue
20
Pages
942-957
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3213060608
Cited by
205
References
3
FWCI
9.89
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. https://app.cochat.ai/papers/10.1212/wnl.0000000000012868
The paper
Pringsheim, T., Day, G. S., Smith, D. B., Rae-Grant, A., Licking, N., Armstrong, M. J., de Bie, R. M. A., Roze, E., Miyasaki, J. M., Hauser, R. A., Espay, A. J., Martello, J. P., Gurwell, J. A., Billinghurst, L., Sullivan, K., Fitts, M. S., Cothros, N., Hall, D. A., Rafferty, M., . . . Lang, A. E. (2021). Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. https://doi.org/10.1212/wnl.0000000000012868

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.